Looking at the 2021 annual report vs 2020, I can see that all but 1 of DEV's Julimar tenement applications have moved from application to granted.
It appears DEV now have 5 Julimar tenements, not including Sovereign Hill. From what I can see all 5 are to the south of Julimar. I have not heard any developments re those holdings - has anyone else?
If I was to speculate... I imagine DEV has enough on their plate, what with 12km intrusion to properly explore at Sovereign Hill... plus the other projects in NSW and NT.
Perhaps they are also closely watching the exploration campaigns of other companies around those southern tenements (such as ASN, PUR, MAN etc.) and seeing if they have hit anything of interest. From what I can see, nothing of significant interest has been hit... so no urgency to do anything... yet.
Save the $$ for Sovereign campaign I'd say.
FWIW, your question has just allowed me to see that DEV now has application for land in QLD...
- Forums
- ASX - By Stock
- DEV
- Ann: Investor Presentation - September 2021
Ann: Investor Presentation - September 2021, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $50.79M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.0¢ | $38.81K | 335.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 20589 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 72664 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 20589 | 0.115 |
12 | 252535 | 0.110 |
3 | 107142 | 0.105 |
3 | 60000 | 0.100 |
1 | 100000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 72664 | 2 |
0.125 | 103334 | 2 |
0.130 | 199999 | 1 |
0.140 | 57142 | 2 |
0.145 | 323221 | 4 |
Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
Featured News
DEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online